Daunorubicin (0-256 μg/mL, 30 min) inhibits DNA and RNA synthesis in sensitive and resistant Ehrlich ascites tumor cells.
Daunorubicin (7 nM-1.9 μM, 72 h) shows chemosensitivity in Molt-4 cells and L3.6 cells.
Daunorubicin (0.4 μM, 48 h) induces apoptotic and necrosis in L3.6 cells.
Daunorubicin (0.4 μM, 120 min) induces ROS generation in L3.6 cells.
Daunorubicin (2 μM, 24 h) induces autophagy in K562 cells (myeloid cell line).
Cell Viability Assay
| Cell Line: |
Molt-4 cells (a human T-lymphoblastic leukemia cell line), L3.6 cells (metastatic human pancreatic cell line) |
| Concentration: |
7 nM-1.9 μM |
| Incubation Time: |
72 hours |
| Result: |
Inhibited cell viability with IC50 values of 40 nM (Molt-4) and 400 nM (L3.6). |
Apoptosis Analysis
| Cell Line: |
L3.6 cells |
| Concentration: |
0.4 μM |
| Incubation Time: |
24, 48 hours |
| Result: |
Induced necrosis without apoptosis at 24 h, induced both an apoptotic and extensive necrotic response at 48 h. |
Western Blot Analysis
| Cell Line: |
K562 cells |
| Concentration: |
2 μM |
| Incubation Time: |
24 hours |
| Result: |
Enabled the switch of LC3-I into LC3-II, accompanied with a significant increased expression level of LC3. |